Literature DB >> 19166928

Gastrointestinal growth factors and hormones have divergent effects on Akt activation.

Marc J Berna1, Jose A Tapia, Veronica Sancho, Michelle Thill, Andrea Pace, K Martin Hoffmann, Lauro Gonzalez-Fernandez, Robert T Jensen.   

Abstract

Akt is a central regulator of apoptosis, cell growth and survival. Growth factors and some G-protein-coupled receptors (GPCR) regulate Akt. Whereas growth-factor activation of Akt has been extensively studied, the regulation of Akt by GPCR's, especially gastrointestinal hormones/neurotransmitters, remains unclear. To address this area, in this study the effects of GI growth factors and hormones/neurotransmitters were investigated in rat pancreatic acinar cells which are high responsive to these agents. Pancreatic acini expressed Akt and 5 of 7 known pancreatic growth-factors stimulate Akt phosphorylation (T308, S473) and translocation. These effects are mediated by p85 phosphorylation and activation of PI3K. GI hormones increasing intracellular cAMP had similar effects. However, GI-hormones/neurotransmitters [CCK, bombesin, carbachol] activating phospholipase C (PLC) inhibited basal and growth-factor-stimulated Akt activation. Detailed studies with CCK, which has both physiological and pathophysiological effects on pancreatic acinar cells at different concentrations, demonstrated CCK has a biphasic effect: at low concentrations (pM) stimulating Akt by a Src-dependent mechanism and at higher concentrations (nM) inhibited basal and stimulated Akt translocation, phosphorylation and activation, by de-phosphorylating p85 resulting in decreasing PI3K activity. This effect required activation of both limbs of the PLC-pathway and a protein tyrosine phosphatase, but was not mediated by p44/42 MAPK, Src or activation of a serine phosphatase. Akt inhibition by CCK was also found in vivo and in Panc-1 cancer cells where it inhibited serum-mediated rescue from apoptosis. These results demonstrate that GI growth factors as well as gastrointestinal hormones/neurotransmitters with different cellular basis of action can all regulate Akt phosphorylation in pancreatic acinar cells. This regulation is complex with phospholipase C agents such as CCK, because both stimulatory and inhibitory effects can be seen, which are mediated by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166928      PMCID: PMC2677382          DOI: 10.1016/j.cellsig.2009.01.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  120 in total

1.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

2.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.

Authors:  Verónica Sancho; María V Trigo; Nieves González; Isabel Valverde; Willy J Malaisse; María L Villanueva-Peñacarrillo
Journal:  J Mol Endocrinol       Date:  2005-08       Impact factor: 5.098

4.  Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation.

Authors:  Hiroaki Watanabe; Hiroshi Saito; Piotr G Rychahou; Tatsuo Uchida; B Mark Evers
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

5.  Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2.

Authors:  Ursula G B Haider; Thomas U Roos; Maria I Kontaridis; Benjamin G Neel; Dan Sorescu; Kathy K Griendling; Angelika M Vollmar; Verena M Dirsch
Journal:  Mol Pharmacol       Date:  2005-04-22       Impact factor: 4.436

6.  Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival.

Authors:  Qiao-Ling Cui; Wen-Hua Zheng; Remi Quirion; Guillermina Almazan
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

7.  Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.

Authors:  Renée Germack; Martin Griffin; John M Dickenson
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

8.  Supraphysiologic concentrations of cerulein induce apoptosis in the rat pancreatic acinar cell line AR4-2J.

Authors:  N Sata; H Klonowski-Stumpe; B Han; R Lüthen; D Häussinger; C Niederau
Journal:  Pancreas       Date:  1999-07       Impact factor: 3.327

9.  SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.

Authors:  B Cuevas; Y Lu; S Watt; R Kumar; J Zhang; K A Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

10.  The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt.

Authors:  Annabel Rose; Pascal Froment; Valérie Perrot; Michael J Quon; Derek LeRoith; Joëlle Dupont
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

View more
  18 in total

1.  The Src kinase Yes is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters, but not pancreatic growth factors, which stimulate its association with numerous other signaling molecules.

Authors:  Veronica Sancho; Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2012-05-19

2.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

3.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 4.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

5.  Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.

Authors:  Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2015-05-12

Review 6.  Regulation of acinar cell function in the pancreas.

Authors:  John A Williams
Journal:  Curr Opin Gastroenterol       Date:  2010-09       Impact factor: 3.287

7.  Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.

Authors:  Irene Ramos-Álvarez; Lingaku Lee; Robert T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

8.  P21-activated kinase 4 in pancreatic acinar cells is activated by numerous gastrointestinal hormones/neurotransmitters and growth factors by novel signaling, and its activation stimulates secretory/growth cascades.

Authors:  Irene Ramos-Alvarez; R T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-19       Impact factor: 4.052

Review 9.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

10.  Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.

Authors:  Paola Moreno; Samuel A Mantey; Bernardo Nuche-Berenguer; Marc L Reitman; Nieves González; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2013-07-26       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.